Synonym
Alifedrine hydrochloride, Alifedrine HCl; D 13625; D-13625; D13625;
IUPAC/Chemical Name
(R-(R*,S*))-1-Cyclohexyl-3-((2-hydroxy-1-methyl-2-phenylethyl)amino)propan-1-one
InChi Key
UEELVIXXTBPOCF-KSSFIOAISA-N
InChi Code
InChI=1S/C18H27NO2/c1-14(18(21)16-10-6-3-7-11-16)19-13-12-17(20)15-8-4-2-5-9-15/h3,6-7,10-11,14-15,18-19,21H,2,4-5,8-9,12-13H2,1H3/t14-,18-/m0/s1
SMILES Code
O=C(C1CCCCC1)CCN[C@@H](C)[C@H](O)C2=CC=CC=C2
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
289.42
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Anand IS, Hughes LO, Whittington JR, Raftery EB. Acute haemodynamic effects of different doses of alifedrine in congestive heart failure. Eur J Clin Pharmacol. 1989;36(4):335-41. PubMed PMID: 2737225.
2: Wan SK, Hoff W, Evans TR. Haemodynamic effects of intravenous and oral alifedrine in patients with cardiac failure. Curr Med Res Opin. 1988;11(4):242-53. PubMed PMID: 3215041.
3: Schanzenbächer P, Riegger G, Liebau G, Hockerts T, Kochsiek K. [Acute hemodynamic effects of alifedrine in patients with heart failure]. Z Kardiol. 1984 Feb;73(2):95-100. German. PubMed PMID: 6719988.
4: Wainwright CL, Parratt JR. Alifedrine, a positive inotropic agent that moderately reduces the severity of ischaemia and reperfusion-induced ventricular arrhythmias. Eur J Pharmacol. 1988 Mar 15;147(3):373-80. PubMed PMID: 3378563.
5: Metzenauer P, Dedecke R, Göbel H, Martorana PA, Stroman F, Szelenyi I. Effects of the novel beta-adrenergic partial agonist alifedrine on cardiac performance in dogs with acute ischemic left ventricular failure. J Cardiovasc Pharmacol. 1989 Jul;14(1):103-8. PubMed PMID: 2475700.
6: Engel J, Bekel H, Heiliger D, Schaumlöffel E. [14C-labeling of alifedrine hydrochloride, a new positive inotropic compound]. Arch Pharm (Weinheim). 1985 May;318(5):465-7. German. PubMed PMID: 4026541.
7: Bickel E, Engel J, Klingler KH. [Syntheses of 14C-1-erythro-norephedrine and its N-substitution products 14C-oxyfedrine and 14C-D 13,625]. Arzneimittelforschung. 1983;33(9):1213-5. German. PubMed PMID: 6685500.
8: Colucci WS, Wright RF, Braunwald E. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. N Engl J Med. 1986 Feb 6;314(6):349-58. Review. PubMed PMID: 2418353.